Replies to post #71105 on CV Sciences Inc (CVSI)

[ap17]

Exactly. Opps! nice catch there. The R & B missed it entirely.

[Gladys Thong]

NEWS FLASH! CVSI-007/Cantine is CHEWING GUM


https://tradersnewssource.com/cv-sciences/

In December 2015, CV Sciences acquired CanX Inc., a pre-clinical drug development company focused on significant unmet medical needs. The initial drug candidate (CVSI-007) is a chewing gum containing nicotine and synthetic CBD to support cessation of smokeless tobacco use and addiction. The product is in the pre-clinical stage.

"CV Sciences, Inc. Issues Letter to Shareholders" September 27, 2016

Multi-billion market opportunity presented by initial drug candidate (CVSI-007), a proprietary chewing gum that combines synthetic CBD and nicotine to effectively treat smokeless tobacco addiction.

etc., etc, . . . ad nauseam

CV Sciences has been dangling this CHEWING GUM in front of investors for 5 years !


AND APIRx Pharmaceuticals appears WELL-AHEAD in that CVSI-007/Cantine market